JPM vs NAVI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Navient Corporation exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a completely bearish technical trend (0/100). While the stock appears cheap on a Price-to-Book basis (0.33), this is likely a value trap given the catastrophic revenue decline of -54.90% YoY and negative profit margins. The dividend is fundamentally unsustainable with a 200% payout ratio, and the extreme Debt/Equity ratio of 19.09 indicates precarious leverage. Recent earnings performance is dismal, with zero beats in the last four quarters and massive negative surprises.
Compare Another Pair
Related Comparisons
JPM vs NAVI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Navient Corporation (NAVI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.